# FDA Inspection 1326644 - Continental Services Group, Inc. - June 29, 2026

Source: https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/71716b59-b250-45b3-a8f5-e58e89b56e67
Source feed: FDA_Inspections

> FDA Inspection 1326644 for Continental Services Group, Inc. on June 29, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1326644
- Company Name: Continental Services Group, Inc.
- Inspection Date: 2026-06-29
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Florida District Office

## Related Documents

- [FDA Inspection 1239104 - 2024-05-21](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/bace115f-0095-4b44-9371-fa77a52685a0)
- [FDA Inspection 1178110 - 2022-08-24](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/59c7d5d1-6a5a-46ac-8e84-bca592b6933b)
- [FDA Inspection 1178110 - 2022-08-24](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/863a919f-b7c6-4ee1-a12f-df26270d21cb)
- [FDA Inspection 1096414 - 2019-07-09](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/0506e847-6917-4d56-baf8-a6a0a19814fa)
- [FDA Inspection 1023396 - 2017-08-22](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/7f1d4708-484f-4a85-b019-598b8d1f7b0f)

Company: https://www.keypedia.com/companies/continental-services-group-inc/6a7a7180-4020-4fc8-a2f2-ca4ab032c3a4

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9